Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Shingo Kozono

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3898-6373; OpenAlex author ID A5003928051. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2012: 3 papers · 2013: 6 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 14

  1. Outcomes of Resected Cases of Pancreatic Ductal Adenocarcinoma Patients With Unexpected Postoperative Uncovering Noncurative Factors: A Multicenter Retrospecti… Co-author DOI 10.1002/ags3.70090↗
  2. Association between preoperative exercise tolerance and unplanned readmission in patients who underwent pancreatectomy for pancreatic ductal adenocarcinoma: a … First author DOI 10.1186/s12885-025-13466-9↗
  3. Association between Preoperative Exercise Tolerance, Comorbidities, and Survival Rates in Patients with Pancreatic Cancer. First author DOI 10.31662/jmaj.2025-0105↗
  4. Safe exposure of the left renal vein during laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: anatomical variations and pitfalls. Co-author DOI 10.1007/s00595-020-02053-z↗
  5. Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer. Co-author DOI 10.3892/ijo.2014.2391↗
  6. MAL2 expression predicts distant metastasis and short survival in pancreatic cancer. Co-author DOI 10.1016/j.surg.2013.03.010↗
  7. A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice. Co-author DOI 10.1097/mpa.0b013e3182649979↗
  8. Kindlin-2 expression in peritumoral stroma is associated with poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e318279bd66↗
  9. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Co-author DOI 10.1158/0008-5472.can-12-3180↗
  10. Kindlin-1 expression is involved in migration and invasion of pancreatic cancer. Co-author DOI 10.3892/ijo.2013.1838↗
  11. S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells. Co-author DOI 10.3892/or.2013.2636↗
  12. Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer. Co-author DOI 10.1111/j.1349-7006.2011.02113.x↗
  13. Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition. Co-author DOI 10.1371/journal.pone.0040434↗
  14. CD271⁺ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells. Co-author DOI 10.1371/journal.pone.0052682↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Makoto Onji · 2 shared papers, 2025 · strength 0.63
  2. Koichi Naito · 2 shared papers, 2025 · strength 0.63
  3. Naoki Ikenaga · 8 shared papers, 2012–2026 · strength 0.46
  4. Kenoki Ohuchida · 10 shared papers, 2012–2014 · strength 0.33
  5. Masao Tanaka · 10 shared papers, 2012–2014 · strength 0.33
  6. Takao Ohtsuka · 8 shared papers, 2012–2014 · strength 0.26
  7. Yasuhisa Mori · 2 shared papers, 2013–2026 · strength 0.26
  8. Masafumi Nakamura · 2 shared papers, 2013–2026 · strength 0.26
  9. Toru Hisaka · 1 shared paper, 2026 · strength 0.23
  10. Teijiro Hirashita · 1 shared paper, 2026 · strength 0.23
  11. Hiromitsu Hayashi · 1 shared paper, 2026 · strength 0.23
  12. Tomoharu Yoshizumi · 1 shared paper, 2026 · strength 0.23
  13. Hiroaki Nagano · 1 shared paper, 2026 · strength 0.23
  14. Susumu Eguchi · 1 shared paper, 2026 · strength 0.23
  15. Hirokazu Noshirο · 1 shared paper, 2026 · strength 0.23
  16. Hiroto Matsui Matsui · 1 shared paper, 2026 · strength 0.23
  17. Hirohisa Okabe · 1 shared paper, 2026 · strength 0.23
  18. Daiki Eguchi · 6 shared papers, 2012–2014 · strength 0.20
  19. Kenji Fujiwara · 6 shared papers, 2012–2014 · strength 0.20
  20. Lin Cui · 4 shared papers, 2013–2014 · strength 0.14
  21. Ming Zhao · 4 shared papers, 2012–2013 · strength 0.13
  22. Koji Shindo · 4 shared papers, 2012–2013 · strength 0.13
  23. Yuichi Nagakawa · 1 shared paper, 2020 · strength 0.11
  24. Hitoe Nishino · 1 shared paper, 2020 · strength 0.11
  25. Akihiko Tsuchida · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.